Taevas
New ZealandPharmaceuticals
Product Registration
Market Access for Product-Registration in New Zealand
Navigating the complexities of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve timely and profitable market entry across diverse interna
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies & Local Health Authorities
Timeline
6-8 weeks (for initial strategy)
Deliverables
Strategic Report, Market Access Roadmap, P&R Strategy
What We Deliver
6 Pillars of Global Market Access for Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
Understanding the intricate and ever-evolving regulatory landscape across key global markets is foundational. We provide in-depth analysis of country-specific requirements, submission pathways, and approval timelines.
Horizon Scanning & Landscape Analysis
Country-Specific Regulatory Roadmaps
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Scope Definition
We begin with an in-depth consultation to understand your product, target markets, clinical data, and strategic objectives. This phase defines the scope and critical success factors for your global market access strategy.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Fragmented Global Regulatory Landscape
The absence of a unified global regulatory framework necessitates tailored strategies for each region, increasing complexity and the potential for delays in product registration and market entry.
Rising Importance of Real-World Evidence
Regulatory bodies and payers increasingly demand robust real-world evidence alongside clinical trial data to demonstrate long-term value and effectiveness, impacting both registration and reimbursement success.
Pressure on Pricing & Value Demonstration
Healthcare systems globally are under increasing budgetary pressure, demanding stronger value propositions and cost-effectiveness data for new products to achieve favorable pricing and reimbursement.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic recommendations for regulatory pathways, HTA, pricing, and reimbursement across target markets.
Country-Specific Regulatory & Payer Landscape Analysis
Detailed reports on the specific requirements, challenges, and opportunities within your chosen global markets.
Value Proposition & Messaging Framework
A tailored framework to articulate your product's unique value to regulators, payers, and healthcare professionals globally.
Implementation Roadmap & Action Plan
A step-by-step guide for executing your market access strategy, complete with timelines, responsibilities, and key milestones.
Who This Is For
Use Cases
New Market Entry
Launch of a Novel Biologic in Asia-Pacific
A pharmaceutical company sought to register and launch a groundbreaking biologic across multiple Asia-Pacific countries, each with distinct regulatory and HTA requirements.
Outcome
Taevas developed a harmonized regional strategy, accelerating registration and achieving optimal pricing in key markets.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Unlock the full potential of your innovative life sciences products. Partner with Taevas Life Sciences to navigate global complexities and secure successful market entry.
Accelerated Regulatory Approvals
Optimized Reimbursement & Pricing
Reduced Market Entry Risks
Maximized Product Value